Talk:CA15-3

How widely is it used

Sounds like it was experimental in 2006. Do any national health services use it as normal practice ? Rod57 (talk) 18:00, 15 December 2009 (UTC)[reply]

"normal" levels

In general, a rise in CA 15-3 levels may indicate a larger aggregate tumor biomass. Marked increase may be seen if the breast cancer spreads (metastasizes) to other organs, such as into the bones or the liver.

A person without breast cancer will generally have a level of CA 15-3 of 30 or lower. However a result in this range does not definitively rule out cancer. 25% to 30% of breast cancers do not raise CA 15-3 levels.

Ocdncntx (talk) 20:15, 5 October 2011 (UTC)[reply]

combination of CA 15-3 and CEA diagnostic specificity was 97%excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits." PMID 7652495

"The diagnostic specificity was 97%. ... The combination of CA 15-3 and CEA is an excellent for detection and exclusion of recurrence in the follow-up of breast cancer patients if decision-making is based on individual reference limits."

PMID 7652495

Hölzel WG, Beer R, Deschner W, Griesmacher A, Müller MM.

Individual reference ranges of CA 15-3, MCA and CEA in recurrence of breast cancer.

Scand J Clin Lab Invest Suppl. 1995; 221:93-101. — Preceding unsigned comment added by Ocdncntx (talk • contribs) 20:19, 5 October 2011 (UTC)[reply]

Duplicate page

There are two CA15-3 pages. Both appear to be stubs, but clearly one should be pointed at the other.drh (talk) 18:30, 20 January 2013 (UTC)[reply]